Resolute Capital Asset Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$676K	–	45
2022 Q3	$676K	Buy	+4,000	New	+$676K	0.61%	40